Get the tools used by (smart)2 investors.

Current Portion of LT Debt & Capital Leases for Amphastar P

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

AMPH: Amphastar P

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, ...

24.19 USD
Price
USD
Fair Value
Upside
22.64 - 53.95
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Amphastar P's Current Portion of LT Debt & Capital Leases:

Dec 2016Dec 2018Dec 2020Dec 2022Dec 20240 K5 M10 M15 M20 M

Performance Summary
  • Amphastar P's current portion of lt debt & capital leases last quarter was 7.038 million
  • Amphastar P's current portion of lt debt & capital leases for fiscal years ending December 2020 to 2024 averaged 7.647 million.
  • Amphastar P's operated at median current portion of lt debt & capital leases of 6.049 million from fiscal years ending December 2020 to 2024.
  • Looking back at the last 5 years, Amphastar P's current portion of lt debt & capital leases peaked in December 2020 at 15.62 million.
  • Amphastar P's current portion of lt debt & capital leases hit its 5-year low in December 2023 of 4.342 million.
  • Amphastar P's current portion of lt debt & capital leases decreased in 2021 (5.184 million, -66.8%) and 2023 (4.342 million, -28.2%) and increased in 2020 (15.62 million, +43.1%), 2022 (6.049 million, +16.7%), and 2024 (7.038 million, +62.1%).

How does Amphastar P's Current Portion of LT Debt & Capital Leases benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Amphastar P because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Metric Usage: Current Portion of LT Debt & Capital Leases

Hide this widget
current_port_debt_leases
Slug
number
Datatype
text
Format
current
Default Period
FY, Q
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Current Portion of LT Debt & Capital Leases in the financials category include:

  • Cost of Revenues - This expense item reflects the direct costs associated with revenues including cost of goods sold.
  • Book Value / Share - The book value of common equity on a per basic share basis.
  • Other Intangibles - This item represents the net values of those assets (i.e. gross intangibles less accumulated amortization), which provide future economic benefit to the enterprise but have no physical form. It also includes the combined net amount of "Goodwill and Intangibles" (i.e. gross goodwill and intangibles as reduced by the accumulated amortization), where it is not possible to separately identify net goodwill and net intangibles.
  • Land - This item represents the Assets of a durable nature in the form of Land held by the company, at their gross values, which are to be used in the production or sale of goods, sale of other goods or rendering of services rather than being held for sale.
View Full List

Search for metric or datapoint

Current Portion of LT Debt & Capital Leases

The portion of long term debt and capital leases which is due in the upcoming year.

Definition of Current Portion of LT Debt & Capital Leases

Hide this widget

Amphastar Pharmaceuticals reported current portion of lt debt & capital leases of 7.038 M for the latest quarter ending December 31, 2024 on its balance sheet.

The tables below summarizes Amphastar Pharmaceuticals’s Current Portion of LT Debt & Capital Leases and common size over the last five years:

Fiscal YearCurrent Portion of LT Debt & Capital LeasesAssets% Assets
2020-12-3115.62 M631.2 M2.5%
2021-12-315.184 M671.5 M0.8%
2022-12-316.049 M742 M0.8%
2023-12-314.342 M1.513 B0.3%
2024-12-317.038 M1.577 B0.4%

The tables below summarizes Amphastar Pharmaceuticals’s Current Portion of LT Debt & Capital Leases and common size over the last four quarters:

Quarter EndingCurrent Portion of LT Debt & Capital LeasesAssets% Assets
2024-03-314.37 M1.574 B0.3%
2024-06-304.245 M1.492 B0.3%
2024-09-304.461 M1.545 B0.3%
2024-12-317.038 M1.577 B0.4%

Click the link below to download a spreadsheet with an example Current Portion of LT Debt & Capital Leases calculation for Amphastar P below:

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
0 K250 M500 M875.4 M05001,0001,5002,000

The chart above depicts the distribution of current portion of lt debt & capital leases for companies operating in the Healthcare sector in the Developed economic region. Over 2,390 companies were considered in this analysis, and 2,346 had meaningful values. The average current portion of lt debt & capital leases of companies in the sector is 17.236 M with a standard deviation of 70.409 M.

Amphastar P's Current Portion of LT Debt & Capital Leases of 7.038 M ranks in the 78.0% percentile for the sector. The following table provides additional summary stats:

Current Portion of LT Debt & Capital Leases In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents2,394
Included Constituents2,346
Min0 K
Max860.9 M
Median645.653 K
Mean17.236 M
Standard Deviation70.409 M

You can find companies with similar current portion of lt debt & capital leases using this stock screener.

All rights reserved. Terms Of Use